Sign Up Today and Learn More About TrialSpark Stock
Invest in or calculate the value of your shares in TrialSpark or other pre-IPO companies through EquityZen's platform.
TrialSpark Stock (TRSA)
TrialSpark is a technology company that helps bring treatments to patients faster by reimagining how clinical trials are run.
About TrialSpark Stock
Founded
2014
Headquarters
New York, NY, US
Industries
Software, Data and Analytics, Science and Engineering
TrialSpark Press Mentions
Stay in the know about the latest news on TrialSpark
Appointments and advancements for April 7, 2025
bioworld • Apr 08, 2025
Verrica Pharmaceuticals Inc. (VRCA) named Gavin Corcoran MD to board
streetinsider • Apr 08, 2025
Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of Directors
biospace • Apr 03, 2025
Mikael Dolsten Joins Formation Bio to Chair Drug Picking Committee and Co-Chair its Investment Advisory Committee
citybiz • Apr 03, 2025
Former Pfizer R&D Chief Mikael Dolsten Joins Formation Bio to Chair Drug Picking Committee and Co-Chair its Investment Advisory Committee
prnewswire • Apr 02, 2025
Investors in TrialSpark
Discover investors in TrialSpark stock and explore their portfolio companies
TrialSpark Management
Leadership team at TrialSpark
CEO and Co-Founder
Benjamine Liu
CTO and Co-Founder
Linhao Zhang
Join now and verify your accreditation status to gain access to:
- TrialSpark Current Valuation
- TrialSpark Stock Price
- TrialSpark Management
- Available deals in TrialSpark and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- TrialSpark Cap Table and Funding History by Share Class and Liquidity Preferences
- TrialSpark Revenue and Financials
- TrialSpark Highlights
- TrialSpark Business Model
- TrialSpark Risk Factors
- TrialSpark Research Report from SACRA Research
Trading TrialSpark Stock
How to invest in TrialSpark stock?
Accredited investors can buy pre-IPO stock in companies like TrialSpark through EquityZen funds. These investments are made available by existing TrialSpark shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell TrialSpark stock?
Shareholders can sell their TrialSpark stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
